Insider · CIK 0001413006
George A Eldridge
Files at JBIO (Aerovate Therapeutics, Inc.). First filing Mar 11, 2024, latest Jun 14, 2024.
In brief
George A Eldridge files SEC Form 4 as officer at JBIO (Aerovate Therapeutics, Inc.). Since Mar 11, 2024, George A Eldridge has reported 0 open-market buys worth $0 and 5 open-market sells worth $1.7M, the latest filed on Jun 14, 2024.
A track record needs three past buys with six months of prices behind them; George A Eldridge has 0, so none is measured yet.
The newest scored trade: sold $375k of JBIO on Jun 14, 2024, filed Jun 14, 2024, scored 31 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
JBIO: Aerovate Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | Aerovate Therapeutics, Inc. | $375k 15,000 shares | -75% | +157% from low-20% from high | |
| 27Weak | Aerovate Therapeutics, Inc. | $201k 7,500 shares | -79% | +182% from low-12% from high | |
| 31Weak | Aerovate Therapeutics, Inc. | $390k 12,495 shares | -86% | +221% from low0% from high | |
| 25Weak | Aerovate Therapeutics, Inc. | $102k 4,067 shares | -101% | +152% from low-9% from high | |
| 35Weak | Aerovate Therapeutics, Inc. | $649k 25,933 shares | -107% | +155% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 1, 2024 | JBIO Aerovate Therapeutics, Inc. | 37,400 0.13% of outstanding | $1.1M | Apr 1, 2024 | $751k |
| Mar 7, 2024 | JBIO Aerovate Therapeutics, Inc. | 30,000 0.11% of outstanding | $716k | Mar 7, 2024 | none |
Transactions
Every row this insider has filed, 28 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 14, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +15,000 | $2.14 | $32k | 20,022 | Jun 14, 2024 |
| Jun 14, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -15,000 | $25.03 | $375k | 5,022 | Jun 14, 2024 |
| Jun 14, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 28,763 | Jun 14, 2024 |
| Apr 10, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +7,500 | $2.14 | $16k | 9,460 | Apr 12, 2024 |
| Apr 10, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,729 | $26.77 | $180k | 2,731 | Apr 12, 2024 |
| Apr 10, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -771 | $27.56 | $21k | 1,960 | Apr 12, 2024 |
| Apr 10, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -7,500 | $0.00 | $0 | 43,763 | Apr 12, 2024 |
| Apr 1, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +12,495 | $2.14 | $27k | 14,455 | Apr 3, 2024 |
| Apr 1, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -12,495 | $31.23 | $390k | 1,960 | Apr 3, 2024 |
| Apr 1, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -12,495 | $0.00 | $0 | 15,768 | Apr 3, 2024 |
| Mar 12, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +2,051 | $2.14 | $4,389 | 4,011 | Mar 14, 2024 |
| Mar 12, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,051 | $25.05 | $51k | 1,960 | Mar 14, 2024 |
| Mar 13, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +2,016 | $2.14 | $4,314 | 3,976 | Mar 14, 2024 |
| Mar 13, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,016 | $25.02 | $50k | 1,960 | Mar 14, 2024 |
| Mar 12, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,051 | $0.00 | $0 | 53,279 | Mar 14, 2024 |
| Mar 13, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,016 | $0.00 | $0 | 51,263 | Mar 14, 2024 |
| Mar 7, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +22,386 | $2.14 | $48k | 24,346 | Mar 11, 2024 |
| Mar 7, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -22,386 | $25.00 | $560k | 1,960 | Mar 11, 2024 |
| Mar 8, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +114 | $2.14 | $244 | 2,074 | Mar 11, 2024 |
| Mar 8, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -114 | $25.00 | $2,850 | 1,960 | Mar 11, 2024 |
| Mar 11, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +3,433 | $2.14 | $7,347 | 5,393 | Mar 11, 2024 |
| Mar 11, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,423 | $25.24 | $86k | 1,970 | Mar 11, 2024 |
| Mar 11, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -10 | $26.31 | $263 | 1,960 | Mar 11, 2024 |
| Mar 7, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,400 | $0.00 | $0 | 28,263 | Mar 11, 2024 |
| Mar 7, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,986 | $0.00 | $0 | 58,877 | Mar 11, 2024 |
| Mar 8, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -114 | $0.00 | $0 | 58,763 | Mar 11, 2024 |
| Mar 11, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,433 | $0.00 | $0 | 55,330 | Mar 11, 2024 |
| Jan 22, 2024 | JBIO Aerovate Therapeutics, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +66,586 | $0.00 | $0 | 66,586 | Jan 24, 2024 |
Questions about George A Eldridge
Answered from the filings on this page, as of the latest one.
Is George A Eldridge buying or selling?
Not in the last 12 months. George A Eldridge's latest open-market trade on SEC Form 4 was sold $375k of JBIO on Jun 14, 2024.
How did George A Eldridge's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and George A Eldridge has 0.
Where does George A Eldridge file Form 4?
George A Eldridge has filed Form 4 at JBIO (Aerovate Therapeutics, Inc.) as SEE REMARKS. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.